Effect of tofacitinib on lipid levels and lipid-related parameters in patients with moderate to severe psoriasis

While small increases in lipid levels are observed with tofacitinib treatment in patients with psoriasis, effects on selected lipid-related parameters and other circulating CV risk biomarkers are not suggestive of an increased CV risk [NCT01276639].